Literature DB >> 10822089

K(+) channel-blocking alkoxypsoralens inhibit the immune response of encephalitogenic T line cells and lymphocytes from Lewis rats challenged for experimental autoimmune encephalomyelitis.

U Strauss1, K Wissel, S Jung, H Wulff, W Hänsel, J Zhu, A Rolfs, E Mix.   

Abstract

Alkoxypsoralens, known as DNA photomodifying agents, have been shown to block voltage-dependent K(+) channels (Kv) as well as to alleviate functional deficits in certain multiple sclerosis (MS) patients in a manner similar to 4-aminopyridine. Since Kv channel blockers are known to inhibit T cell-mediated immune responses both in vitro and in vivo, we investigated the effects of three alkoxypsoralens, 5-methoxypsoralen (5-MOP), 8-methoxypsoralen (8-MOP), and 5,8-diethoxypsoralen (H37), on the following parameters: (1) whole-cell K(+) currents of encephalitogenic, myelin basic protein-specific memory T cell line cells (MBP-TCLC) derived from Lewis rats as measured by patch-clamp technique, (2) proliferation of MBP-TCLC and lymph node cells (LNC) from Lewis rats challenged for experimental autoimmune encephalomyelitis (EAE) by immunisation with spinal cord homogenate as measured by 3H-thymidine incorporation, (3) interferon-gamma (IFN-gamma) secretion of MBP-TCLC as measured by ELISA, and (4) IFN-gamma gene expression of LNC as measured by quantitative reverse transcription polymerase chain reaction (RT-PCR) with ELISA-detection. The examined alkoxypsoralens exhibited suppressive effects on the measured parameters with the same sequence of efficacy: H37>5-MOP>8-MOP. We, therefore, conclude that Kv channel-blocking alkoxypsoralens interfere with voltage-controlled signal transduction in lymphocytes and might thereby suppress immune responses in autoimmune diseases of the central nervous system and most likely also in other autoimmune disorders. Thus, alkoxypsoralens, especially the non-phototoxic substance H37, are new candidates for further studies on K(+) channel blocking immunosuppressive drugs. The agents may exert a dual beneficial effect on demyelinating diseases like MS, because they could attenuate the inflammatory process and improve axonal conductivity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10822089     DOI: 10.1016/s0162-3109(00)00177-6

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  6 in total

Review 1.  Molecular properties and physiological roles of ion channels in the immune system.

Authors:  M D Cahalan; H Wulff; K G Chandy
Journal:  J Clin Immunol       Date:  2001-07       Impact factor: 8.317

Review 2.  Immunology and neurology.

Authors:  Eilhard Mix; Robert Goertsches; Uwe K Zettl
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

Review 3.  Animal models of multiple sclerosis for the development and validation of novel therapies - potential and limitations.

Authors:  Eilhard Mix; Hans Meyer-Rienecker; Uwe K Zettl
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

Review 4.  Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).

Authors:  Cris S Constantinescu; Nasr Farooqi; Kate O'Brien; Bruno Gran
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

5.  Constitutive expression of bergaptol O-methyltransferase in Glehnia littoralis cell cultures.

Authors:  Aya Ishikawa; Tatsuya Kuma; Hiroyuki Sasaki; Nobuhiro Sasaki; Yoshihiro Ozeki; Nobuyuki Kobayashi; Yoshie Kitamura
Journal:  Plant Cell Rep       Date:  2008-10-31       Impact factor: 4.570

Review 6.  Animal models of multiple sclerosis--potentials and limitations.

Authors:  Eilhard Mix; Hans Meyer-Rienecker; Hans-Peter Hartung; Uwe K Zettl
Journal:  Prog Neurobiol       Date:  2010-06-15       Impact factor: 11.685

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.